GLI1 and hepatocellular carcinoma: We have demonstrated that Hh transcription factors GLI1/2 were able to bind to the consensus sequence in the promoter of ABCC1 or ABCB2 to facilitate resistance to sorafenib, doxorubicin and cisplatin in poorly differentiated hepatoma cells.